- Global Pharma News & Resources

Headache Disorders Market Overview | Competitive Dashboard, Segment Analysis, Global Trend, Growth and Strategies by 2023-2030

A worldwide Headache Disorders market research report offers an array of insights about Headache Disorders industry and business solutions that will support to stay ahead of the competition. A systematic investment analysis is also underlined in this report which forecasts impending opportunities for the market players. This market report is the outcome of persistent efforts lead by knowledgeable forecasters, innovative analysts and brilliant researchers who carries out detailed and diligent research on different markets, trends and emerging opportunities in the consecutive direction for the business needs. Headache Disorders market report analyzes the Headache Disorders industry from top to bottom by considering myriad of aspects.

Data Bridge Market Research analyses a growth rate in the headache disorders market in the forecast period 2023-2030. The expected CAGR of headache disorders market is tend to be around 6.4% in the mentioned forecast period. The market was valued at USD 3.99 billion in 2022, and it would grow up to USD 6.55 billion by 2030.

Get Sample PDF Copy (Including FULL TOC, Graphs And Tables) Of This Report @

Companies Mentioned in Headache Disorders Market:

  1. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (US), Merck & Co., Inc. (US), Allergan (Ireland), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Cipla Inc. (US), Amneal Pharmaceuticals LLC. (US), Eisai Co., Ltd. (Japan), Bausch Health Companies Inc. (Canada), Abbott (US), Takeda Pharmaceutical Company Limited (Japan), WOCKHARDT (Mumbai), AbbVie Inc. (US), Merck KGaA (Germany)

The titled segments and sub-section of the market are illuminated below

By Type (Migraine, Tension-type headache, Cluster Headache , Medication-overuse headache, Others)

By Diagnosis (Complete Blood Count, Skull X-rays, Sinus X-rays, CT Scan, MRI, Others)

By Treatment (Drugs, Therapy, Others)

By Route of Administration (Oral, Parenteral, Others)

By End-Users (Hospitals, Specialty Clinics, Others)

By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)

Headache Disorders Market Defination

Headache disorders is the most widespread nervous system disorders which are typically characterized by consistent headaches. Headache is an extreme and disabling symptom of a few major headache disorders, which includes migraine, cluster headache, tension-type headache and others. Another incident cause of headache is overuse of medication. Antipsychotic medications, antiseizure medications, calcium channel blockers, antidepressants, and nonsteroidal anti-inflammatory drugs (NSAIDs) are the numerous drugs used in the treatment of headache disorders.

Global Headache Disorders Market Dynamics


  • Rising Cases of Depression

The increasing number of cases of depression is a primary factor boosting the headache disorders market’s growth rate during the forecast period of 2023-2030. Unhealthy lifestyle of people such as high alcohol consumption, severe changes in eating or sleeping pattern are the major risk factors which is expanding the frequency of depression and further causing headache. Additionally, emotional stress associated with family and friends, school or work is anticipated to boost the market’s growth rate during the forecast period.

  • Increased Healthcare Expenditure

A major factor prompting the growth rate of headache disorders market is the increasing healthcare expenditure that helps in improving its improved infrastructure. Moreover, numerous government organizations aims to improve the healthcare infrastructure by growing funding and this will in turn influence the market dynamics. Thus, it boost the market growth.

To Receive Extensive List Of Important Regions, Ask For TOC Here @ 

Table Of Content: Global Headache Disorders Market Research Report

The report is mainly segmented into several key regions, with sales, revenue, market share and growth rate of Headache Disorders in these regions, covering:

  • Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.
  • Executive Summary: It covers industry trends with high focus on market use cases and top market trends, Headache Disorders market share by regions, and global market size. It also covers market share and growth rate by regions.
  • Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.
  • Breakdown by Segmentation: This section provides details about Global Headache Disorders market size by product and application.
  • Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.
  • Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.
  • Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges, opportunities, and drivers analyzed in the report.
  • Key Findings of the Research Study
  • Appendix: It includes details about research and methodology approach, research methodology, data sources, authors of the study, and a disclaimer.

This Report Lets You Identify The Opportunities In Headache Disorders Market Size By Means Of A Region:

  • North America (the United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Turkey, etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam)
  • South America (Brazil etc.)
  • The Middle East and Africa (North Africa and GCC Countries)

Recent Development

  • In 2021, FDA had approved the first and only oral CGRP receptor antagonist called QULIPTA, which is particularly developed for the preventive treatment of migraine. CGRP and its receptors are used for nervous system that is related with migraine pathogenesis, and CGRP levels have been found to be more during migraine attacks in studies. QULIPTA is a once-daily medication that blocks CGRP. It comes in three different dosage forms including 10 mg, 30 mg, and 60 mg.

Feel Free To Ask Question Before Purchasing The Report @

Report Highlights:

  • Shifting Industry dynamics
  • In-depth Headache Disorders Market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Growth Outlook Predictions Through Forecast
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • Import and Export Probabilities, Developments at Sales Outcome And Revenue Generation Predictions.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Headache Disorders Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter’s 5 force model. The impact of Covid-19 on the market is also featured in the report.

View Full Report:

Top Related Reports:

Global Endobronchial Ultrasound Biopsy Devices Market:

Global Respiratory Masks Market:

Europe Respiratory Masks Market:

Asia-Pacific Respiratory Masks Market:

Middle East and Africa Respiratory Masks Market:

North America Respiratory Masks Market:

Global Mucolipidosis II(I cell Disorder) Market:

Global Dracunculiasis Disease market:

Global Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market:

Global Hereditary Sensory Motor Neuropathy Market:

Global Anesthesia Circuits Market:

Global Lumasiran Market:

Global PORCN inhibitor market:

Global lopinavir/ritonavir Market:

Explore DBMR Comprehensive Coverage on Healthcare Domain:

Global Fallopian Tube Cancer Treatment Market:

Global Computed Radiography Market:

Global Abetalipoproteinemia Treatment Market:

Global Neurosurgical Drills Market:

Global High Flow Needle Sets Market:

Global Anterior Horn Cell Disease Market:

Global Anti-MAG peripheral neuropathy Treatment market:

Global Waardenburg Syndrome Market:

Global Bronchiectasis Market:

Europe Bronchiectasis Market:

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Editor Details

  • Company:
    • The Wire Times
Last Updated: 26-May-2023